Pharmaceutical Product Development, Llc And Neogenomics Laboratories, Inc Partnered To Molecular Testing Solution For Molecular Cytogenetics Market
In June 2018, Pharmaceutical Product Development, LLC (PPD), a global contract research organization (CRO), and NeoGenomics Laboratories, Inc., a provider of cancer-focused genetic testing services have formed a strategic alliance to offer a seamless and fully integrated global pathology and molecular testing solution to PPD’s pharmaceutical and biotech clients.
The high burden of genetic disorders and cancer around the globe is propelling the growth of the molecular cytogenetics market. According to the National Institutes of Health, about 1 in 200,000 people in the United States are diagnosed with syndrome A each year. An estimated 15,000 people worldwide were diagnosed with syndrome B last year. The growing use of molecular cytogenetic products in academic research institutes, clinical and research laboratories, and pharmaceutical and biotechnology industries are again expected to uplift the growth of the market. Moreover, increasing activities in pharmacogenomics are also projected to foster the growth of the molecular cytogenetics market.
On the other hand, unfavorable reimbursement policies across developing countries are expected to restrict the growth of the market over the forecast period.
North America is expected to hold the dominant position in the global molecular cytogenetics market and this is attributed to the high prevalence of cancer in the region. According to the National Cancer Institute, as of January 2019, there were an estimated 16.9 million cancer survivors in the United States. The number of cancer survivors is projected to increase to 22.2 million by 2030. Also, the presence of an effective regulatory framework for the regulation of genetic tests is further anticipated to bolster the growth of the market.
Molecular cytogenetic techniques have recently been developed as one of the methods used in molecular biology studies. It is a process where genetic information is manipulated by introducing specific DNA sequences and changing the function of the chromosomes without affecting the other proteins or genes being affected. This technique has greatly contributed to the field of molecular biology, as it allows for the study of single genes without affecting the rest of the genome. In addition, molecular cytogenetics can be used to study the effect of environmentally induced changes on gene regulation and thus on environmental and health applications such as controlling and monitoring human diseases.
Molecular cytogenetic techniques are used in many fields of research. They can be used to study the molecular basis of illness and disease, and the effects of environmental factors on the human body. They can also be used to study the role of sex hormones, pollutants, and carcinogens on the development of newborns and children, the consequences of maternal diet during pregnancy, and the consequences of paternal transmission of inherited diseases.
Comments
Post a Comment